Seller record · Telehealth service

Aquivia Health

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: The pricing page identifies compounded GLP-1 products but does not plainly state that they are not FDA-approved on the public offer. 1 more criterion also fails; see the table below.

At a glance

Aquivia HealthTelehealth service

6/8criteria passed

Price: Printed on its own pages before sign-up
Sells: compounded semaglutide, compounded tirzepatide
FDA letters: None on file

Visit Aquivia Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A clinician-led telehealth platform with compounded GLP-1 programs, named pharmacy partners and prepaid shipment plans whose billing units are four weeks.

Operating entity Aquivia Health, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Aquivia Health's pricing page
S2	Prescription gating	PASS	Aquivia Health's pricing page
S3	Pharmacy identification	PASS	Aquivia Health's terms and conditions
S4	Compounding disclosure	FAIL	Aquivia Health's pricing page; Aquivia Health's GLP-1 page
S5	Analytical documentation	FAIL	Aquivia Health's pricing page; Aquivia Health's GLP-1 page; Aquivia Health's FAQ
S6	Business address	PASS	Aquivia Health's privacy policy
S7	Price disclosure	PASS	Aquivia Health's pricing page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed clinician reviews the health and eligibility information and determines whether treatment is appropriate before prescribing.Source: Aquivia Health's pricing page.

S2PASSThe published sequence starts with health questions, followed by clinician review and medication shipment only if prescribed.Source: Aquivia Health's pricing page.

S3PASSThe terms identify RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx with addresses and telephone numbers.Source: Aquivia Health's terms and conditions.

S4FAILThe pricing page identifies compounded GLP-1 products but does not plainly state that they are not FDA-approved on the public offer.Source: Aquivia Health's pricing page; Aquivia Health's GLP-1 page.

S5FAILThe pricing, GLP-1 and FAQ pages publish no certificate of analysis or equivalent lot document.Source: Aquivia Health's pricing page; Aquivia Health's GLP-1 page; Aquivia Health's FAQ.

S6PASSThe privacy policy lists Aquivia Health, LLC at 12750 Jefferson Davis Highway #322, Chester, VA 23831.Source: Aquivia Health's privacy policy.

S7PASSThe displayed 52-week semaglutide plan is $2,327 upfront for 13 shipments, or $179 per shipment. Tirzepatide is $3,497 upfront for 13 shipments, or $269 per shipment. Shipment intervals are four weeks. The separately displayed summer discount ended in August and is not a current offer.Source: Aquivia Health's pricing page.

S8PASSNo FDA warning letter names Aquivia Health or Aquivia Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Aquivia Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.